Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
Sponsor: Anhui Provincial Hospital
Summary
Evaluating the safety and effectiveness of a CD25 monoclonal antibody-based prophylactic acute graft-versus-host-disease (aGVHD) regimen following unrelated umbilical cord blood transplantation (UCBT) for malignant hematologic disorders in reducing severe aGVHD.
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
39
Start Date
2024-07-01
Completion Date
2027-06-30
Last Updated
2024-06-28
Healthy Volunteers
No
Interventions
Basiliximab
Addition of CD25 monoclonal antibody(Basiliximab) at +3 days post unrelated umbilical cord blood transplantation (UCBT)
Locations (1)
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Hefei, China